Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
    September 2021
    SARS-CoV-2 Variant Antibodies Wane 6 Months After Vaccination.
    JAMA. 2021;326:901.
    >> Share

    Adolescent Myocarditis After COVID-19 Vaccination Is Rare.
    JAMA. 2021;326:902.
    >> Share

  3. KHARBANDA EO, Haapala J, DeSilva M, Vazquez-Benitez G, et al
    Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy.
    JAMA. 2021 Sep 8. pii: 2784193. doi: 10.1001/jama.2021.15494.
    >> Share

  4. BLUMENTHAL KG, Phadke NA, Bates DW
    Safety Surveillance of COVID-19 mRNA Vaccines Through the Vaccine Safety Datalink.
    JAMA. 2021 Sep 3. pii: 2784017. doi: 10.1001/jama.2021.14808.
    >> Share

  5. KLEIN NP, Lewis N, Goddard K, Fireman B, et al
    Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
    JAMA. 2021 Sep 3. pii: 2784015. doi: 10.1001/jama.2021.15072.
    >> Share

  6. JONES JM, Stone M, Sulaeman H, Fink RV, et al
    Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
    JAMA. 2021 Sep 2. pii: 2784013. doi: 10.1001/jama.2021.15161.
    >> Share

    August 2021
  7. STEENSELS D, Pierlet N, Penders J, Mesotten D, et al
    Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273.
    JAMA. 2021 Aug 30. pii: 2783797. doi: 10.1001/jama.2021.15125.
    >> Share

  8. EVANS A, Webster J, Flores G
    Partnering With the Faith-Based Community to Address Disparities in COVID-19 Vaccination Rates and Outcomes Among US Black and Latino Populations.
    JAMA. 2021;326:609-610.
    >> Share

  9. SCHAEFER GO, Leland RJ, Emanuel EJ
    Making Vaccines Available to Other Countries Before Offering Domestic Booster Vaccinations.
    JAMA. 2021 Aug 12. pii: 2783234. doi: 10.1001/jama.2021.13226.
    >> Share

  10. ABBASI J
    Oldest Adults Need 2 mRNA Vaccine Doses to Neutralize SARS-CoV-2.
    JAMA. 2021;326:473.
    >> Share

  11. ABBASI J
    COVID-19 mRNA Vaccines Blunt Breakthrough Infection Severity.
    JAMA. 2021;326:473.
    >> Share

  12. DIAZ GA, Parsons GT, Gering SK, Meier AR, et al
    Myocarditis and Pericarditis After Vaccination for COVID-19.
    JAMA. 2021 Aug 4. pii: 2782900. doi: 10.1001/jama.2021.13443.
    >> Share

    July 2021
  13. ABBASI J
    Uberantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines.
    JAMA. 2021 Jul 28. pii: 2782673. doi: 10.1001/jama.2021.12915.
    >> Share

  14. RUBIN R
    Higher Medicare Payments for In-home COVID-19 Vaccinations.
    JAMA. 2021;326:298.
    >> Share

  15. KUEHN BM
    Resurgence of Pertussis Linked With Switch to Acellular Vaccine.
    JAMA. 2021;326:300.
    >> Share

  16. BENOTMANE I, Gautier G, Perrin P, Olagne J, et al
    Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses.
    JAMA. 2021 Jul 23. pii: 2782538. doi: 10.1001/jama.2021.12339.
    >> Share

  17. BATES TA, Leier HC, Lyski ZL, Goodman JR, et al
    Age-Dependent Neutralization of SARS-CoV-2 and P.1 Variant by Vaccine Immune Serum Samples.
    JAMA. 2021 Jul 21. pii: 2782428. doi: 10.1001/jama.2021.11656.
    >> Share

  18. ABBASI J
    Study Suggests Lasting Immunity After COVID-19, With a Big Boost From Vaccination.
    JAMA. 2021 Jul 14. pii: 2782139. doi: 10.1001/jama.2021.11717.
    >> Share

  19. GOLDSHTEIN I, Nevo D, Steinberg DM, Rotem RS, et al
    Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.
    JAMA. 2021 Jul 12. pii: 2782047. doi: 10.1001/jama.2021.11035.
    >> Share

  20. NUTI SV, Armstrong K
    Lay Epidemiology and Vaccine Acceptance.
    JAMA. 2021 Jul 7. pii: 2781943. doi: 10.1001/jama.2021.11130.
    >> Share

  21. WALKEY AJ, Law A, Bosch NA
    Lottery-Based Incentive in Ohio and COVID-19 Vaccination Rates.
    JAMA. 2021 Jul 2. pii: 2781792. doi: 10.1001/jama.2021.11048.
    >> Share

  22. SANCHEZ VAN KAMMEN M, Heldner MR, Brodard J, Scutelnic A, et al
    Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.
    JAMA. 2021 Jul 2. pii: 2781791. doi: 10.1001/jama.2021.9889.
    >> Share

  23. KAVANAGH MM, Gostin LO, Sunder M
    Sharing Technology and Vaccine Doses to Address Global Vaccine Inequity and End the COVID-19 Pandemic.
    JAMA. 2021 Jul 1. pii: 2781756. doi: 10.1001/jama.2021.10823.
    >> Share

  24. PERSAD G, Emanuel EJ
    Ethical Considerations of Offering Benefits to COVID-19 Vaccine Recipients.
    JAMA. 2021 Jul 1. pii: 2781755. doi: 10.1001/jama.2021.11045.
    >> Share

    June 2021
  25. RUBIN R
    The Search for a Single Vaccine Against Coronaviruses Yet to Come.
    JAMA. 2021 Jun 23. pii: 2781521. doi: 10.1001/jama.2021.9477.
    >> Share

  26. RUBIN R
    Vaccination in Residential Facilities.
    JAMA. 2021;325:2426.
    >> Share

  27. GONZALEZ DC, Nassau DE, Khodamoradi K, Ibrahim E, et al
    Sperm Parameters Before and After COVID-19 mRNA Vaccination.
    JAMA. 2021 Jun 17. pii: 2781360. doi: 10.1001/jama.2021.9976.
    >> Share

  28. BERTOLLINI R, Chemaitelly H, Yassine HM, Al-Thani MH, et al
    Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar.
    JAMA. 2021 Jun 9. pii: 2781112. doi: 10.1001/jama.2021.9970.
    >> Share

  29. AZZIZ-BAUMGARTNER E, Grohskopf L, Patel M
    Realizing the Potential of Maternal Influenza Vaccination.
    JAMA. 2021;325:2257-2259.
    >> Share

  30. MEHRABADI A, Dodds L, MacDonald NE, Top KA, et al
    Association of Maternal Influenza Vaccination During Pregnancy With Early Childhood Health Outcomes.
    JAMA. 2021;325:2285-2293.
    >> Share

    COVID-19 Vaccination of Health Care Personnel as a Condition of Employment: A Logical Addition to Institutional Safety Programs.
    JAMA. 2021 Jun 7. pii: 2781011. doi: 10.1001/jama.2021.8901.
    >> Share

  32. GOSTIN LO, Shaw J, Salmon DA
    Mandatory SARS-CoV-2 Vaccinations in K-12 Schools, Colleges/Universities, and Businesses.
    JAMA. 2021 Jun 7. pii: 2781010. doi: 10.1001/jama.2021.9342.
    >> Share

  33. RYAN L
    Vaccinated but Not Protected-Living Immunocompromised During the Pandemic.
    JAMA. 2021 Jun 7. pii: 2781012. doi: 10.1001/jama.2021.9321.
    >> Share

  34. WOOD S, Schulman K
    When Vaccine Apathy, Not Hesitancy, Drives Vaccine Disinterest.
    JAMA. 2021 Jun 2. pii: 2780792. doi: 10.1001/jama.2021.7707.
    >> Share

    May 2021
  35. HOTEZ PJ, Narayan KMV
    Restoring Vaccine Diplomacy.
    JAMA. 2021 May 28. pii: 2780640. doi: 10.1001/jama.2021.7439.
    >> Share

  36. AL KAABI N, Zhang Y, Xia S, Yang Y, et al
    Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial.
    JAMA. 2021 May 26. pii: 2780562. doi: 10.1001/jama.2021.8565.
    >> Share

  37. RUBIN R
    Allergic Reactions to mRNA Vaccines.
    JAMA. 2021;325:2038.
    >> Share

  38. DALY M, Jones A, Robinson E
    Public Trust and Willingness to Vaccinate Against COVID-19 in the US From October 14, 2020, to March 29, 2021.
    JAMA. 2021 May 24. pii: 2780519. doi: 10.1001/jama.2021.8246.
    >> Share

  39. UYEKI TM, Wentworth DE, Jernigan DB
    Influenza Activity in the US During the 2020-2021 Season.
    JAMA. 2021 May 24. pii: 2780518. doi: 10.1001/jama.2021.6125.
    >> Share

  40. COLLIER AY, McMahan K, Yu J, Tostanoski LH, et al
    Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women.
    JAMA. 2021 May 13. pii: 2780202. doi: 10.1001/jama.2021.7563.
    >> Share

  41. ABBASI J
    Personalized Cancer Vaccine Approach Safe in Early Trial.
    JAMA. 2021;325:1825.
    >> Share

  42. KUEHN BM
    Even Partial COVID-19 Vaccination Protects Nursing Home Residents.
    JAMA. 2021;325:1826.
    >> Share

  43. KUEHN BM
    Vaccine Dramatically Reduces HPV Infection Among Young Women.
    JAMA. 2021;325:1826.
    >> Share

  44. TANG L, Hijano DR, Gaur AH, Geiger TL, et al
    Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce.
    JAMA. 2021 May 6. pii: 2779854. doi: 10.1001/jama.2021.6564.
    >> Share

  45. ANGEL Y, Spitzer A, Henig O, Saiag E, et al
    Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    JAMA. 2021 May 6. pii: 2779853. doi: 10.1001/jama.2021.7152.
    >> Share

  46. BOYARSKY BJ, Werbel WA, Avery RK, Tobian AAR, et al
    Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.
    JAMA. 2021 May 5. pii: 2779852. doi: 10.1001/jama.2021.7489.
    >> Share

    April 2021
  47. SEE I, Su JR, Lale A, Woo EJ, et al
    US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.
    JAMA. 2021 Apr 30. pii: 2779731. doi: 10.1001/jama.2021.7517.
    >> Share

  48. KARRON RA, Key NS, Sharfstein JM
    Assessing a Rare and Serious Adverse Event Following Administration of the Ad26.COV2.S Vaccine.
    JAMA. 2021 Apr 30. pii: 2779732. doi: 10.1001/jama.2021.7637.
    >> Share

  49. RUBIN R
    Vaccination Priorities Delay Shots for Higher-Risk People of Color.
    JAMA. 2021;325:1601.
    >> Share

  50. RUBIN R
    Medicare Raises Payment for Administering COVID-19 Vaccines.
    JAMA. 2021;325:1601.
    >> Share

  51. CHEN MM, Mott N, Clark SJ, Harper DM, et al
    HPV Vaccination Among Young Adults in the US.
    JAMA. 2021;325:1673-1674.
    >> Share

  52. KUEHN BM
    Israel's Real-life Evidence That Vaccine Can Prevent Severe COVID-19.
    JAMA. 2021;325:1603.
    >> Share

  53. BLAIN H, Tuaillon E, Gamon L, Pisoni A, et al
    Spike Antibody Levels of Nursing Home Residents With or Without Prior COVID-19 3 Weeks After a Single BNT162b2 Vaccine Dose.
    JAMA. 2021 Apr 15. pii: 2778926. doi: 10.1001/jama.2021.6042.
    >> Share

  54. Experts Discuss COVID-19-Variants and Vaccine Efficacy, Immunosuppressed Patients, and More.
    JAMA. 2021 Apr 14. pii: 2778876. doi: 10.1001/jama.2021.5938.
    >> Share

  55. ABBASI J
    Data Leak Exposes Early COVID-19 Vaccine Manufacturing Hiccups.
    JAMA. 2021;325:1385.
    >> Share

  56. PERL SH, Uzan-Yulzari A, Klainer H, Asiskovich L, et al
    SARS-CoV-2-Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women.
    JAMA. 2021 Apr 12. pii: 2778766. doi: 10.1001/jama.2021.5782.
    >> Share

  57. GOSTIN LO, Cohen IG, Shaw J
    Digital Health Passes in the Age of COVID-19: Are "Vaccine Passports" Lawful and Ethical?
    JAMA. 2021 Apr 7. pii: 2778526. doi: 10.1001/jama.2021.5283.
    >> Share

  58. CHAPIN-BARDALES J, Gee J, Myers T
    Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines.
    JAMA. 2021 Apr 5. pii: 2778441. doi: 10.1001/jama.2021.5374.
    >> Share

    March 2021
  59. RUBIN R
    HHS Expands Number of People Who Can Vaccinate Against COVID-19.
    JAMA. 2021;325:1134.
    >> Share

    The Coronavirus Pandemic 1 Year On-What Went Wrong?
    JAMA. 2021;325:1132-1133.
    >> Share

  61. EDARA VV, Hudson WH, Xie X, Ahmed R, et al
    Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination.
    JAMA. 2021 Mar 19. pii: 2777898. doi: 10.1001/jama.2021.4388.
    >> Share

  62. Experts Discuss COVID-19-Vaccine Questions, School Openings, and More.
    JAMA. 2021 Mar 17. pii: 2777786. doi: 10.1001/jama.2021.4121.
    >> Share

  63. RUBIN R
    COVID-19 Vaccines vs Variants-Determining How Much Immunity Is Enough.
    JAMA. 2021 Mar 17. pii: 2777785. doi: 10.1001/jama.2021.3370.
    >> Share

    2020 Revealed How Poorly the US Was Prepared for COVID-19-and Future Pandemics.
    JAMA. 2021;325:1029-1030.
    >> Share

  65. BOYARSKY BJ, Werbel WA, Avery RK, Tobian AAR, et al
    Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.
    JAMA. 2021 Mar 15. pii: 2777685. doi: 10.1001/jama.2021.4385.
    >> Share

  66. WILF-MIRON R, Myers V, Saban M
    Incentivizing Vaccination Uptake: The "Green Pass" Proposal in Israel.
    JAMA. 2021 Mar 15. pii: 2777686. doi: 10.1001/jama.2021.4300.
    >> Share

  67. STEPHENSON KE, Le Gars M, Sadoff J, de Groot AM, et al
    Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19.
    JAMA. 2021 Mar 11. pii: 2777598. doi: 10.1001/jama.2021.3645.
    >> Share

  68. CHRISTIE A, Mbaeyi SA, Walensky RP
    CDC Interim Recommendations for Fully Vaccinated People: An Important First Step.
    JAMA. 2021 Mar 10. pii: 2777536. doi: 10.1001/jama.2021.4367.
    >> Share

  69. BLUMENTHAL KG, Robinson LB, Camargo CA Jr, Shenoy ES, et al
    Acute Allergic Reactions to mRNA COVID-19 Vaccines.
    JAMA. 2021 Mar 8. pii: 2777417. doi: 10.1001/jama.2021.3976.
    >> Share

  70. MOORE JP
    Approaches for Optimal Use of Different COVID-19 Vaccines: Issues of Viral Variants and Vaccine Efficacy.
    JAMA. 2021 Mar 4. pii: 2777390. doi: 10.1001/jama.2021.3465.
    >> Share

  71. DEL RIO C, Malani P
    COVID-19 in 2021-Continuing Uncertainty.
    JAMA. 2021 Mar 4. pii: 2777391. doi: 10.1001/jama.2021.3760.
    >> Share

  72. MURRAY CJL, Piot P
    The Potential Future of the COVID-19 Pandemic: Will SARS-CoV-2 Become a Recurrent Seasonal Infection?
    JAMA. 2021 Mar 3. pii: 2777343. doi: 10.1001/jama.2021.2828.
    >> Share

  73. SAADAT S, Tehrani ZR, Logue J, Newman M, et al
    Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2.
    JAMA. 2021 Mar 1. pii: 2777171. doi: 10.1001/jama.2021.3341.
    >> Share

  74. LIVINGSTON EH, Malani PN, Creech CB
    The Johnson & Johnson Vaccine for COVID-19.
    JAMA. 2021 Mar 1. pii: 2777172. doi: 10.1001/jama.2021.2927.
    >> Share

    February 2021
  75. CREECH CB, Walker SC, Samuels RJ
    SARS-CoV-2 Vaccines.
    JAMA. 2021 Feb 26. pii: 2777059. doi: 10.1001/jama.2021.3199.
    >> Share

  76. GHARPURE R, Patel A, Link-Gelles R
    First-Dose COVID-19 Vaccination Coverage Among Skilled Nursing Facility Residents and Staff.
    JAMA. 2021 Feb 24. pii: 2777023. doi: 10.1001/jama.2021.2352.
    >> Share

  77. RUBIN R
    Pregnant People's Paradox-Excluded From Vaccine Trials Despite Having a Higher Risk of COVID-19 Complications.
    JAMA. 2021 Feb 24. pii: 2777024. doi: 10.1001/jama.2021.2264.
    >> Share

  78. RUBIN R
    The Price of Success-How to Evaluate COVID-19 Vaccines When They're Available Outside of Clinical Trials.
    JAMA. 2021 Feb 18. pii: 2776787. doi: 10.1001/jama.2021.0641.
    >> Share

  79. WALENSKY RP, Walke HT, Fauci AS
    SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities.
    JAMA. 2021 Feb 17. pii: 2776739. doi: 10.1001/jama.2021.2294.
    >> Share

  80. KUEHN BM
    High-Income Countries Have Secured the Bulk of COVID-19 Vaccines.
    JAMA. 2021;325:612.
    >> Share

  81. SHARFSTEIN JM, Goodman JL, Borio L
    The US Regulatory System and COVID-19 Vaccines: The Importance of a Strong and Capable FDA.
    JAMA. 2021 Feb 15. pii: 2776658. doi: 10.1001/jama.2021.1961.
    >> Share

    Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021.
    JAMA. 2021 Feb 12. pii: 2776557. doi: 10.1001/jama.2021.1967.
    >> Share

  83. Experts Discuss COVID-19-Vaccine Doses, Virus Variants, and More.
    JAMA. 2021 Feb 10. pii: 2776539. doi: 10.1001/jama.2021.1101.
    >> Share

  84. BIANCHI DW, Kaeser L, Cernich AN
    Involving Pregnant Individuals in Clinical Research on COVID-19 Vaccines.
    JAMA. 2021 Feb 10. pii: 2776540. doi: 10.1001/jama.2021.1865.
    >> Share

  85. ADHIKARI EH, Spong CY
    COVID-19 Vaccination in Pregnant and Lactating Women.
    JAMA. 2021 Feb 8. pii: 2776449. doi: 10.1001/jama.2021.1658.
    >> Share

  86. RASMUSSEN SA, Jamieson DJ
    Pregnancy, Postpartum Care, and COVID-19 Vaccination in 2021.
    JAMA. 2021 Feb 8. pii: 2776447. doi: 10.1001/jama.2021.1683.
    >> Share

    A Viral Pandemic, Vaccine Safety, and Compensation for Adverse Events.
    JAMA. 2021 Feb 5. pii: 2776308. doi: 10.1001/jama.2020.26792.
    >> Share

    Necessity of 2 Doses of the Pfizer and Moderna COVID-19 Vaccines.
    JAMA. 2021 Feb 3. pii: 2776229. doi: 10.1001/jama.2021.1375.
    >> Share

    January 2021
  89. JEAN-JACQUES M, Bauchner H
    Vaccine Distribution-Equity Left Behind?
    JAMA. 2021 Jan 29. pii: 2776053. doi: 10.1001/jama.2021.1205.
    >> Share

  90. MOORE JP, Offit PA
    SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants.
    JAMA. 2021 Jan 28. pii: 2776039. doi: 10.1001/jama.2021.1114.
    >> Share

  91. LONGHURST CA, Kremer B, Maysent PS
    Rapid Implementation of a Vaccination Superstation.
    JAMA. 2021 Jan 28. pii: 2776038. doi: 10.1001/jama.2021.0801.
    >> Share

    Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine.
    JAMA. 2021 Jan 21. pii: 2775646. doi: 10.1001/jama.2021.0600.
    >> Share

  93. KUEHN BM
    Drop in Vaccination Causes Surge in Global Measles Cases, Deaths.
    JAMA. 2021;325:213.
    >> Share

  94. ABBASI J
    Broad, Durable Antibody Response in Universal Flu Vaccine Trial.
    JAMA. 2021;325:121.
    >> Share

  95. LARGENT EA, Miller FG
    Problems With Paying People to Be Vaccinated Against COVID-19.
    JAMA. 2021 Jan 6. pii: 2775005. doi: 10.1001/jama.2020.27121.
    >> Share

  96. LAURING AS, Hodcroft EB
    Genetic Variants of SARS-CoV-2-What Do They Mean?
    JAMA. 2021 Jan 6. pii: 2775006. doi: 10.1001/jama.2020.27124.
    >> Share

    A 7-Point Action Agenda to End the COVID-19 Pandemic for President-elect Biden.
    JAMA. 2021;325:17-18.
    >> Share

    December 2020
  98. GOSTIN LO, Salmon DA, Larson HJ
    Mandating COVID-19 Vaccines.
    JAMA. 2020 Dec 29. pii: 2774712. doi: 10.1001/jama.2020.26553.
    >> Share

  99. SZILAGYI PG, Thomas K, Shah MD, Vizueta N, et al
    National Trends in the US Public's Likelihood of Getting a COVID-19 Vaccine-April 1 to December 8, 2020.
    JAMA. 2020 Dec 29. pii: 2774711. doi: 10.1001/jama.2020.26419.
    >> Share

  100. RUBIN R
    Pharmacies Partner With HHS to Provide COVID-19 Vaccines.
    JAMA. 2020;324:2475.
    >> Share

  101. KUEHN BM
    Global Regulators Set Standards for Safe Vaccines.
    JAMA. 2020;324:2356.
    >> Share

  102. Experts Discuss COVID-19: Vaccine Allocation, Placebo Groups, and More.
    JAMA. 2020;324:2354-2355.
    >> Share

  103. KRIST AH, Davidson KW, Mangione CM, Barry MJ, et al
    Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2020;324:2415-2422.
    >> Share

  104. JIN J
    Screening for Hepatitis B in Nonpregnant Adolescents and Adults.
    JAMA. 2020;324:2452.
    >> Share

  105. RID A, Lipsitch M, Miller FG
    The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.
    JAMA. 2020 Dec 14. pii: 2774382. doi: 10.1001/jama.2020.25053.
    >> Share

  106. VOLPP KG, Loewenstein G, Buttenheim AM
    Behaviorally Informed Strategies for a National COVID-19 Vaccine Promotion Program.
    JAMA. 2020 Dec 14. pii: 2774381. doi: 10.1001/jama.2020.24036.
    >> Share

  107. JOFFE S
    Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines.
    JAMA. 2020 Dec 14. pii: 2774383. doi: 10.1001/jama.2020.25127.
    >> Share

  108. PATEL MM, Uyeki TM
    Influenza Vaccine for Patients With High-risk Cardiovascular Disease.
    JAMA. 2020 Dec 4. pii: 2773988. doi: 10.1001/jama.2020.23948.
    >> Share

  109. VARDENY O, Kim K, Udell JA, Joseph J, et al
    Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial.
    JAMA. 2020 Dec 4. pii: 2773989. doi: 10.1001/jama.2020.23649.
    >> Share

  110. RODRIGUES FMP, Marlow R, Simoes MJ, Danon L, et al
    Association of Use of a Meningococcus Group B Vaccine With Group B Invasive Meningococcal Disease Among Children in Portugal.
    JAMA. 2020;324:2187-2194.
    >> Share

    November 2020
  111. DESAI AN, Majumder MS
    What Is Herd Immunity?
    JAMA. 2020;324:2113.
    >> Share

  112. LURIE N, Experton B
    How to Leverage the Medicare Program for a COVID-19 Vaccination Campaign.
    JAMA. 2020 Nov 19. pii: 2773348. doi: 10.1001/jama.2020.22720.
    >> Share

  113. LENIS AT, Lec PM, Chamie K, Mshs MD, et al
    Bladder Cancer: A Review.
    JAMA. 2020;324:1980-1991.
    >> Share

  114. SLOMSKI A
    New Guideline Calls for Cervical Cancer Screening to Begin at Age 25 Years.
    JAMA. 2020 Nov 6. pii: 2772859. doi: 10.1001/jama.2020.21706.
    >> Share

  115. UYEKI TM
    High-risk Groups for Influenza Complications.
    JAMA. 2020 Nov 2. pii: 2772692. doi: 10.1001/jama.2020.21869.
    >> Share

  116. UYEKI TM, Santoli J, Jernigan DB
    Preparing for the 2020-2021 Influenza Season.
    JAMA. 2020 Nov 2. pii: 2772691. doi: 10.1001/jama.2020.21849.
    >> Share

    October 2020
    Nursing Homes' Next Test-Vaccinating Workers Against COVID-19.
    JAMA. 2020 Oct 28. pii: 2772581. doi: 10.1001/jama.2020.21354.
    >> Share

  118. BELL BP, Romero JR, Lee GM
    Scientific and Ethical Principles Underlying Recommendations From the Advisory Committee on Immunization Practices for COVID-19 Vaccination Implementation.
    JAMA. 2020 Oct 22. pii: 2772326. doi: 10.1001/jama.2020.20847.
    >> Share

  119. LEE GM, Romero JR, Bell BP
    Postapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the US.
    JAMA. 2020 Oct 16. pii: 2772137. doi: 10.1001/jama.2020.19692.
    >> Share

  120. GOODMAN JL, Grabenstein JD, Braun MM
    Answering Key Questions About COVID-19 Vaccines.
    JAMA. 2020 Oct 16. pii: 2772138. doi: 10.1001/jama.2020.20590.
    >> Share

  121. PATEL MM, Jackson ML, Ferdinands J
    Postlicensure Evaluation of COVID-19 Vaccines.
    JAMA. 2020 Oct 16. pii: 2772136. doi: 10.1001/jama.2020.19328.
    >> Share

  122. SCHMIDT H, Gostin LO, Williams MA
    Is It Lawful and Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?
    JAMA. 2020 Oct 14. pii: 2771874. doi: 10.1001/jama.2020.20571.
    >> Share

  123. Influenza Vaccine for 2020-2021.
    JAMA. 2020 Oct 2. pii: 2771510. doi: 10.1001/jama.2020.19507.
    >> Share

    September 2020
  124. KUEHN BM
    Routine Vaccinations Decline During Pandemic.
    JAMA. 2020;324:1025.
    >> Share

  125. KUEHN BM
    Interest in Global COVID-19 Vaccine Alliance Grows.
    JAMA. 2020;324:1025.
    >> Share

  126. GROHSKOPF LA, Liburd LC, Redfield RR
    Addressing Influenza Vaccination Disparities During the COVID-19 Pandemic.
    JAMA. 2020;324:1029-1030.
    >> Share

  127. ROUERS EDM, Bruijning-Verhagen PCJ, van Gageldonk PGM, van Dongen JAP, et al
    Association of Routine Infant Vaccinations With Antibody Levels Among Preterm Infants.
    JAMA. 2020;324:1068-1077.
    >> Share

  128. O'LEARY ST, Cataldi JR, Lindley MC, Beaty BL, et al
    Policies Among US Pediatricians for Dismissing Patients for Delaying or Refusing Vaccination.
    JAMA. 2020;324:1105-1107.
    >> Share

  129. STEPHENS DS, McElrath MJ
    COVID-19 and the Path to Immunity.
    JAMA. 2020 Sep 11. pii: 2770758. doi: 10.1001/jama.2020.16656.
    >> Share

  130. PERSAD G, Peek ME, Emanuel EJ
    Fairly Prioritizing Groups for Access to COVID-19 Vaccines.
    JAMA. 2020 Sep 10. pii: 2770684. doi: 10.1001/jama.2020.18513.
    >> Share

  131. BAUCHNER H, Malani PN, Sharfstein J
    Reassuring the Public and Clinical Community About the Scientific Review and Approval of a COVID-19 Vaccine.
    JAMA. 2020 Sep 10. pii: 2770681. doi: 10.1001/jama.2020.18860.
    >> Share

  132. CHEN GL
    Chikungunya Virus-Like Particle Vaccine-Reply.
    JAMA. 2020;324:1008-1009.
    >> Share

  133. JAISWAL N, Singh S, Singh M
    Chikungunya Virus-Like Particle Vaccine.
    JAMA. 2020;324:1008.
    >> Share

  134. ABBASI J
    COVID-19 and mRNA Vaccines-First Large Test for a New Approach.
    JAMA. 2020 Sep 3. pii: 2770485. doi: 10.1001/jama.2020.16866.
    >> Share

  135. Rambling Notes of a Roving Doctor.
    JAMA. 2020;324:903.
    >> Share

    August 2020
  136. AVORN J, Kesselheim A
    Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency.
    JAMA. 2020 Aug 31. pii: 2770244. doi: 10.1001/jama.2020.17101.
    >> Share

  137. THOMSON K, Nachlis H
    Emergency Use Authorizations During the COVID-19 Pandemic: Lessons From Hydroxychloroquine for Vaccine Authorization and Approval.
    JAMA. 2020 Aug 31. pii: 2770243. doi: 10.1001/jama.2020.16253.
    >> Share

  138. WALTER K
    Influenza Vaccine.
    JAMA. 2020 Aug 28. pii: 2770159. doi: 10.1001/jama.2020.16846.
    >> Share

    Flu Vaccination Urged During COVID-19 Pandemic.
    JAMA. 2020 Aug 20. pii: 2769836. doi: 10.1001/jama.2020.15444.
    >> Share

  140. GROHSKOPF LA, Liburd LC, Redfield RR
    Addressing Influenza Vaccination Disparities During the COVID-19 Pandemic.
    JAMA. 2020 Aug 20. pii: 2769837. doi: 10.1001/jama.2020.15845.
    >> Share

  141. RUBIN R
    What Happens When COVID-19 Collides With Flu Season?
    JAMA. 2020 Aug 20. pii: 2769835. doi: 10.1001/jama.2020.15260.
    >> Share

  142. WANG EA, Zenilman J, Brinkley-Rubinstein L
    Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities.
    JAMA. 2020 Aug 17. pii: 2769694. doi: 10.1001/jama.2020.15589.
    >> Share

  143. PHADKE VK, Bednarczyk RA, Omer SB
    Vaccine Refusal and Measles Outbreaks in the US.
    JAMA. 2020 Aug 14. pii: 2769677. doi: 10.1001/jama.2020.14828.
    >> Share

    Seasonal Influenza Vaccination.
    JAMA. 2020 Aug 14. pii: 2769679. doi: 10.1001/jama.2020.14772.
    >> Share

  145. SOLOMON DA, Sherman AC, Kanjilal S
    Influenza in the COVID-19 Era.
    JAMA. 2020 Aug 14. pii: 2769676. doi: 10.1001/jama.2020.14661.
    >> Share

  146. XIA S, Duan K, Zhang Y, Zhao D, et al
    Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.
    JAMA. 2020 Aug 13. pii: 2769612. doi: 10.1001/jama.2020.15543.
    >> Share

    Researchers Strive to Recruit Hard-Hit Minorities Into COVID-19 Vaccine Trials.
    JAMA. 2020 Aug 13. pii: 2769611. doi: 10.1001/jama.2020.11244.
    >> Share

    An Inactivated Virus Candidate Vaccine to Prevent COVID-19.
    JAMA. 2020 Aug 13. pii: 2769609. doi: 10.1001/jama.2020.15539.
    >> Share

  149. SHAH A, Marks PW, Hahn SM
    Unwavering Regulatory Safeguards for COVID-19 Vaccines.
    JAMA. 2020 Aug 7. pii: 2769421. doi: 10.1001/jama.2020.15725.
    >> Share

  150. Experts Discuss COVID-19-Remdesivir, Vaccines, and More.
    JAMA. 2020 Aug 5. pii: 2769289. doi: 10.1001/jama.2020.15067.
    >> Share

  151. LURIE N, Sharfstein JM, Goodman JL
    The Development of COVID-19 Vaccines: Safeguards Needed.
    JAMA. 2020;324:439-440.
    >> Share

    July 2020
  152. LEE GM, Bell BP, Romero JR
    The Advisory Committee on Immunization Practices and Its Role in the Pandemic Vaccine Response.
    JAMA. 2020 Jul 22. pii: 2768852. doi: 10.1001/jama.2020.13167.
    >> Share

  153. KUEHN BM
    Diverse HPV Strains Require Strategic Vaccine Use.
    JAMA. 2020;324:223.
    >> Share

  154. WIERSINGA WJ, Rhodes A, Cheng AC, Peacock SJ, et al
    Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
    JAMA. 2020 Jul 10. pii: 2768391. doi: 10.1001/jama.2020.12839.
    >> Share

  155. LURIE N, Sharfstein JM, Goodman JL
    The Development of COVID-19 Vaccines: Safeguards Needed.
    JAMA. 2020 Jul 6. pii: 2768156. doi: 10.1001/jama.2020.12461.
    >> Share

  156. O'CALLAGHAN KP, Blatz AM, Offit PA
    Developing a SARS-CoV-2 Vaccine at Warp Speed.
    JAMA. 2020 Jul 6. pii: 2768155. doi: 10.1001/jama.2020.12190.
    >> Share

  157. DESAI AN, Kim AY
    Management of Hepatitis A in 2020-2021.
    JAMA. 2020 Jul 6. pii: 2768154. doi: 10.1001/jama.2020.4017.
    >> Share

    June 2020
  158. GOSTIN LO, Salmon DA
    The Dual Epidemics of COVID-19 and Influenza: Vaccine Acceptance, Coverage, and Mandates.
    JAMA. 2020 Jun 11. pii: 2767284. doi: 10.1001/jama.2020.10802.
    >> Share

  159. ABBASI J
    Anthony Fauci, MD, on COVID-19 Vaccines, Schools, and Larry Kramer.
    JAMA. 2020 Jun 8. pii: 2767208. doi: 10.1001/jama.2020.9222.
    >> Share

  160. RUBIN R
    Challenge Trials-Could Deliberate Coronavirus Exposure Hasten Vaccine Development?
    JAMA. 2020 Jun 4. pii: 2767024. doi: 10.1001/jama.2020.9881.
    >> Share

  161. Fact and Opinion on the Present Epidemic of Respiratory Disease.
    JAMA. 2020;323:2207.
    >> Share

    May 2020
  162. TROGEN B, Oshinsky D, Caplan A
    Adverse Consequences of Rushing a SARS-CoV-2 Vaccine: Implications for Public Trust.
    JAMA. 2020 May 26. pii: 2766651. doi: 10.1001/jama.2020.8917.
    >> Share

  163. DEL RIO C, Malani P
    Translating Science on COVID-19 to Improve Clinical Care and Support the Public Health Response.
    JAMA. 2020 May 22. pii: 2766600. doi: 10.1001/jama.2020.9252.
    >> Share

  164. SCHAFFER DEROO S, Pudalov NJ, Fu LY
    Planning for a COVID-19 Vaccination Program.
    JAMA. 2020 May 18. pii: 2766370. doi: 10.1001/jama.2020.8711.
    >> Share

  165. COLLINS FS, Stoffels P
    Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): An Unprecedented Partnership for Unprecedented Times.
    JAMA. 2020 May 18. pii: 2766371. doi: 10.1001/jama.2020.8920.
    >> Share

  166. HAMIEL U, Kozer E, Youngster I
    SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults.
    JAMA. 2020 May 13. pii: 2766182. doi: 10.1001/jama.2020.8189.
    >> Share

  167. Serums and Vaccines in Influenza.
    JAMA. 2020;323:1858.
    >> Share

  168. DESAI AN
    Hepatitis E.
    JAMA. 2020;323:1862.
    >> Share

  169. BOLLYKY TJ, Gostin LO, Hamburg MA
    The Equitable Distribution of COVID-19 Therapeutics and Vaccines.
    JAMA. 2020 May 7. pii: 2765944. doi: 10.1001/jama.2020.6641.
    >> Share

  170. HALL MA, Studdert DM
    Privileges and Immunity Certification During the COVID-19 Pandemic.
    JAMA. 2020 May 6. pii: 2765835. doi: 10.1001/jama.2020.7712.
    >> Share

  171. PERSAD G, Emanuel EJ
    The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports").
    JAMA. 2020 May 6. pii: 2765836. doi: 10.1001/jama.2020.8102.
    >> Share

    April 2020
  172. CHEN GL, Coates EE, Plummer SH, Carter CA, et al
    Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes: A Randomized Clinical Trial.
    JAMA. 2020;323:1369-1377.
    >> Share

  173. STAPLEFORD KA, Mulligan MJ
    A New Vaccine for Chikungunya Virus.
    JAMA. 2020;323:1351-1352.
    >> Share

  174. ABBASI J
    FLU-v, a Universal Flu Vaccine Candidate, Advances in Trial.
    JAMA. 2020;323:1336.
    >> Share

    March 2020
  175. SLOMSKI A
    Leading HIV Vaccine Trial Stopped for Ineffectiveness.
    JAMA. 2020;323:1124.
    >> Share

  176. ABBASI J
    Cardiovascular Corner-Stable Coronary Artery Disease, An LDL "Vaccine," and Anti-inflammatories.
    JAMA. 2020 Mar 18. pii: 2763421. doi: 10.1001/jama.2019.20983.
    >> Share

  177. KUEHN BM
    International Measles Vaccination Campaign to Reach Millions.
    JAMA. 2020;323:1033.
    >> Share

  178. KOH HK, Gellin BG
    Measles as Metaphor-What Resurgence Means for the Future of Immunization.
    JAMA. 2020;323:914-915.
    >> Share

    February 2020
  179. WONG JEL, Leo YS, Tan CC
    COVID-19 in Singapore-Current Experience: Critical Global Issues That Require Attention and Action.
    JAMA. 2020 Feb 20. pii: 2761890. doi: 10.1001/jama.2020.2467.
    >> Share

    January 2020
  180. KUEHN B
    Studies Support HPV Safety.
    JAMA. 2020;323:302.
    >> Share

  181. KUEHN BM
    Dengue Vaccine Protects Youth.
    JAMA. 2020;323:209.
    >> Share

  182. KUEHN B
    Pneumococcal Vaccine Recommendation.
    JAMA. 2020;323:112.
    >> Share

  183. OSHMAN LD, Davis AM
    Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    JAMA. 2020 Jan 13. pii: 2758932. doi: 10.1001/jama.2019.18411.
    >> Share

    December 2019
  184. KUEHN B
    Kindergarten Vaccine Coverage Needs a Boost.
    JAMA. 2019;322:2162.
    >> Share

  185. BOULET SL, Chamberlain AT, Biswas HH, Jamieson DJ, et al
    Trends in Infant Pertussis Hospitalizations in the United States, 2009-2017.
    JAMA. 2019;322:2134-2136.
    >> Share

    November 2019
  186. KUEHN B
    Recommended Vaccines Underused During Pregnancy.
    JAMA. 2019;322:1949.
    >> Share

  187. KUEHN B
    Summit Leaders Urge Greater HPV Vaccination in Africa.
    JAMA. 2019;322:1853.
    >> Share

  188. Influenza Vaccine for 2019-2020.
    JAMA. 2019 Nov 6. pii: 2755343. doi: 10.1001/jama.2019.18016.
    >> Share

  189. ABBASI J
    The Search for a Universal Flu Vaccine Heats Up.
    JAMA. 2019 Nov 6. pii: 2755344. doi: 10.1001/jama.2019.16816.
    >> Share

    October 2019
  190. SLOMSKI A
    Experimental Chlamydia Vaccine Shows Promise.
    JAMA. 2019;322:1544.
    >> Share

    Complexity in Assessing the Benefit vs Risk of Vaccines: Experience With Rotavirus and Dengue Virus Vaccines.
    JAMA. 2019 Oct 17. pii: 2753531. doi: 10.1001/jama.2019.16206.
    >> Share

    September 2019
  192. BERKLEY S
    The Power of Vaccines and How Gavi Has Helped Make the World Healthier: 2019 Lasker-Bloomberg Public Service Award.
    JAMA. 2019 Sep 10. pii: 2749793. doi: 10.1001/jama.2019.13190.
    >> Share

  193. GRENNAN D
    JAMA. 2019;322:1022.
    >> Share

  194. CHATURVEDI AK, Graubard BI, Broutian T, Xiao W, et al
    Prevalence of Oral HPV Infection in Unvaccinated Men and Women in the United States, 2009-2016.
    JAMA. 2019;322:977-979.
    >> Share

    July 2019
  195. BASTIDAS A, de la Serna J, El Idrissi M, Oostvogels L, et al
    Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial.
    JAMA. 2019;322:123-133.
    >> Share

  196. PINGALI SC, Delamater PL, Buttenheim AM, Salmon DA, et al
    Associations of Statewide Legislative and Administrative Interventions With Vaccination Status Among Kindergartners in California.
    JAMA. 2019;322:49-56.
    >> Share

  197. DAVIS MM, Shah SK
    Outbreaks of Vaccine-Preventable Diseases: Responding to System Failure With National Vaccination Requirements.
    JAMA. 2019;322:33-34.
    >> Share

    June 2019
  198. POLAND GA, Tilburt JC, Marcuse EK
    Preserving Civility in Vaccine Policy Discourse: A Way Forward.
    JAMA. 2019 Jun 21. pii: 2737023. doi: 10.1001/jama.2019.7445.
    >> Share

    Vaccine Reduces Pneumonia in Kenya.
    JAMA. 2019;321:2273.
    >> Share

  200. CHUN TW, Eisinger RW, Fauci AS
    Durable Control of HIV Infection in the Absence of Antiretroviral Therapy: Opportunities and Obstacles.
    JAMA. 2019 Jun 6. pii: 2735725. doi: 10.1001/jama.2019.5397.
    >> Share

  201. VOELKER R
    Dengue Vaccine Gets the Nod.
    JAMA. 2019;321:2066.
    >> Share

    May 2019
  202. BAIU I, Melendez E
    JAMA. 2019;321:1946.
    >> Share

    April 2019

  203. Medicolegal: Conditions Warranting Requirement of Vaccination.
    JAMA. 2019;321:1638.
    >> Share

  204. RUBIN R
    HHS Funds Development of Vaccine Against Marburg Virus.
    JAMA. 2019;321:1557.
    >> Share

  205. GOSTIN LO, Ratzan SC, Bloom BR
    Safe Vaccinations for a Healthy Nation: Increasing US Vaccine Coverage Through Law, Science, and Communication.
    JAMA. 2019 Apr 19. pii: 2731738. doi: 10.1001/jama.2019.4270.
    >> Share

  206. KUEHN B
    Measles Vaccine Exemptions.
    JAMA. 2019;321:1344.
    >> Share

    March 2019
  207. ABBASI J
    Quick Uptakes: After Rotavirus Vaccine, Australia's Type 1 Diabetes Incidence Declines.
    JAMA. 2019 Mar 13. pii: 2728577. doi: 10.1001/jama.2019.0766.
    >> Share

  208. LINDER KA, Malani PN
    Meningococcal Meningitis.
    JAMA. 2019;321:1014.
    >> Share

  209. HAMPTON T
    Vaccine Protects Mice From Emerging Tick-Borne Flaviviruses.
    JAMA. 2019;321:825-826.
    >> Share

    February 2019
  210. ABU-RAYA B, Edwards KM
    Optimizing the Timing of Vaccine Administration During Pregnancy.
    JAMA. 2019 Feb 25. pii: 2726862. doi: 10.1001/jama.2019.0703.
    >> Share

    January 2019
  211. MEISSNER HC, Nair N, Plotkin SA
    The National Vaccine Injury Compensation Program: Striking a Balance Between Individual Rights and Community Benefit.
    JAMA. 2019 Jan 4. pii: 2720427. doi: 10.1001/jama.2018.20421.
    >> Share

    The Role of the Advisory Committee on Immunization Practices in Ensuring Optimal Use of Vaccines.
    JAMA. 2019 Jan 4. pii: 2720428. doi: 10.1001/jama.2018.20792.
    >> Share

    December 2018
  213. RUBIN R
    Is It Possible to Get a Flu Shot Too Early?
    JAMA. 2018;320:2299-2301.
    >> Share

    November 2018
  214. SLOMSKI A
    Vaccine Prevents Active Tuberculosis.
    JAMA. 2018;320:2068.
    >> Share

  215. SCHLOM J, Gulley JL
    Vaccines as an Integral Component of Cancer Immunotherapy.
    JAMA. 2018 Nov 8. pii: 2714651. doi: 10.1001/jama.2018.9511.
    >> Share

  216. Influenza Vaccine for 2018-2019.
    JAMA. 2018 Nov 2. pii: 2713003. doi: 10.1001/jama.2018.17725.
    >> Share

    October 2018
  217. VOELKER R
    Vulnerability to Pandemic Flu Could Be Greater Today Than a Century Ago.
    JAMA. 2018;320:1523-1525.
    >> Share

  218. KUEHN B
    More Youth Vaccinated for HPV.
    JAMA. 2018;320:1426.
    >> Share

  219. HEALY CM, Rench MA, Swaim LS, Smith EO, et al
    Association Between Third-Trimester Tdap Immunization and Neonatal Pertussis Antibody Concentration.
    JAMA. 2018;320:1464-1470.
    >> Share

    September 2018
  220. FAUCI AS
    Addressing the Tuberculosis Epidemic: 21st Century Research for an Ancient Disease.
    JAMA. 2018 Sep 26. pii: 2702934. doi: 10.1001/jama.2018.12852.
    >> Share

  221. SLOMSKI A
    Study Lays Foundation for TB Vaccine.
    JAMA. 2018;320:1231.
    >> Share

  222. SLOMSKI A
    Mosaic HIV Vaccine Shows Promise.
    JAMA. 2018;320:1231.
    >> Share

    August 2018
  223. VOELKER R
    Pursuing an Effective Ovarian Cancer Vaccine.
    JAMA. 2018 Aug 15. pii: 2697533. doi: 10.1001/jama.2018.10822.
    >> Share

    July 2018
  224. UYEKI TM, Fowler RA, Fischer WA 2nd
    Gaps in the Clinical Management of Influenza: A Century Since the 1918 Pandemic.
    JAMA. 2018 Jul 30. pii: 2695951. doi: 10.1001/jama.2018.8113.
    >> Share

  225. JIN J
    Shingles Vaccination.
    JAMA. 2018;320:416.
    >> Share

    June 2018
  226. RUBIN R
    NIH-Sponsored Trial of Universal Influenza Vaccine.
    JAMA. 2018;319:2469.
    >> Share

    April 2018
  227. SLOMSKI A
    Better Communication Can Improve HPV Vaccine Rates.
    JAMA. 2018;319:1649.
    >> Share

    March 2018
  228. CHEN LH, Hamer DH
    Vaccination Strategies During Shortages of Yellow Fever Vaccine-Reply.
    JAMA. 2018;319:1280-1281.
    >> Share

  229. NORTON SA, Morens DM
    Vaccination Strategies During Shortages of Yellow Fever Vaccine.
    JAMA. 2018;319:1280.
    >> Share

  230. GRAHAM BS, Mascola JR, Fauci AS
    Novel Vaccine Technologies: Essential Components of an Adequate Response to Emerging Viral Diseases.
    JAMA. 2018 Mar 22. pii: 2676502. doi: 10.1001/jama.2018.0345.
    >> Share

  231. JIN J
    HPV Infection and Cancer.
    JAMA. 2018;319:1058.
    >> Share

  232. GLANZ JM, Newcomer SR, Daley MF, DeStefano F, et al
    Association Between Estimated Cumulative Vaccine Antigen Exposure Through the First 23 Months of Life and Non-Vaccine-Targeted Infections From 24 Through 47 Months of Age.
    JAMA. 2018;319:906-913.
    >> Share

    February 2018

  233. A Two-Dose Hepatitis B Vaccine for Adults (Heplisav-B).
    JAMA. 2018;319:822-823.
    >> Share

    January 2018
  234. SLOMSKI A
    Social Media Intervention Improves Vaccine Acceptance.
    JAMA. 2018;319:333.
    >> Share

    December 2017
  235. ABBASI J
    First Phase 1 Trial of a Prophylactic mRNA Vaccine Reported.
    JAMA. 2017;318:2173.
    >> Share

    November 2017
  236. LINDER KA, Malani PN
    Hepatitis A.
    JAMA. 2017 Nov 1. doi: 10.1001/jama.2017.17244.
    >> Share

    October 2017
  237. FAUCI AS
    An HIV Vaccine is Essential for Ending the HIV/AIDS Pandemic.
    JAMA. 2017 Oct 9. doi: 10.1001/jama.2017.13505.
    >> Share

  238. CHEN LH, Hamer DH
    Vaccination Challenges in Confronting the Resurgent Threat From Yellow Fever.
    JAMA. 2017 Oct 5. doi: 10.1001/jama.2017.14258.
    >> Share

  239. CLEMMONS NS, Wallace GS, Patel M, Gastanaduy PA, et al
    Incidence of Measles in the United States, 2001-2015.
    JAMA. 2017;318:1279-1281.
    >> Share

    September 2017
    Progress Stalls in Improving Vaccine Coverage Rates.
    JAMA. 2017;318:995.
    >> Share

  241. LOWY DR, Schiller JT
    Preventing Cancer and Other Diseases Caused by Human Papillomavirus Infection: 2017 Lasker-DeBakey Clinical Research Award.
    JAMA. 2017;318:901-902.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016